LFG
PRCT icon

Larson Financial Group’s Procept Biorobotics PRCT Stock Holding History

Larson Financial Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13K Buy
45
+30
+200% +$845 ﹤0.01% 3119
2025
Q4 		$472 Sell
15
-176
-92% -$5.84K ﹤0.01% 3137
2025
Q3 		$6.82K Buy
191
+176
+1,173% +$8.04K ﹤0.01% 2221
2025
Q2 		$864 Hold
15
– – ﹤0.01% 2688
2025
Q1 		$874 Hold
15
– – ﹤0.01% 2424
2024
Q4 		$1.21K Hold
15
– – ﹤0.01% 1986
2024
Q3 		$1.2K Hold
15
– – ﹤0.01% 1951
2024
Q2 		$916 Buy
+15
New +$892 ﹤0.01% 1727

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Larson Financial Group's PRCT Position: Q1 2026 in Review

Larson Financial Group increased its Procept Biorobotics (PRCT) stake by 200% in Q1 2026, buying an estimated $845 and bringing the position to 45 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #3119.

Larson Financial Group first reported a position in PRCT in Q2 2024 and has held it in 8 quarters since. The position peaked at $6.82K in Q3 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Larson Financial Group held 45 shares of Procept Biorobotics worth $1.13K as of Q1 2026.
  • Larson Financial Group bought 30 Procept Biorobotics shares in Q1 2026, an estimated $845.
  • Procept Biorobotics made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3119 holding.
  • Larson Financial Group first reported a position in Procept Biorobotics in Q2 2024 and has held it in 8 quarters since.
  • Larson Financial Group's Procept Biorobotics position peaked at $6.82K in Q3 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.